)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Attana
Attana (ATANA) investor relations material
Attana Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary28 Aug, 2026
Executive summary
Focused on biosensor development, consumables, and contract research in biotech and pharma sectors.
Strategic initiatives included a CRO pilot with Offspring Biosciences and patent commercialization efforts.
Strengthened commercial presence in the UK and extended key customer agreements.
Evaluating structural partnerships and strategic alternatives to enhance market position.
Financial highlights
Net sales for Jan–Jun 2026 were 0.17 MSEK, down from 0.31 MSEK year-over-year.
Operating result improved to -3.31 MSEK from -3.93 MSEK year-over-year, despite lower sales.
Result after tax was -1.74 MSEK compared to -0.37 MSEK year-over-year.
Total revenue for Q2 2026 was 0.63 MSEK, up from 0.39 MSEK in Q2 2025.
Rights issue raised approximately 13.45 MSEK before costs.
Outlook and guidance
Emphasis on increasing sales, recurring revenues, and strategic collaborations.
Lower cost base and strengthened financial platform expected to support commercial initiatives in H2 2026.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Attana
- Sales declined and losses widened as focus shifted to CRO and commercialization; rights issue planned.ATANA
Q1 2026 - Recurring revenue model and CRO focus drive strategic shift, despite ongoing losses.ATANAQ4 2025
- Net sales nearly doubled and losses narrowed as new business models and IP strategies took shape.ATANAQ3 2025
- Improved financials, new leadership, and strategic initiatives drive future growth.ATANAQ2 2025
- Q3 loss widened on weak sales and one-offs; rights issue planned to secure liquidity.ATANAQ3 2024
- Net loss narrowed and revenue grew in H1 2024, with a positive Q4 outlook pending procurement.ATANAQ2 2024
- Q1 2025 saw improved results, new research, and a strategic CEO transition for Attana.ATANAQ1 2025
- 2024 saw improved losses and capital inflows as Attana targets profitability in 2025.ATANAQ4 2024
Next Attana earnings date
Q3 202627 Nov, 2026
Attana
Next Attana earnings date
Q3 202627 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Attana AB is a Sweden-based biotechnology company specializing in real-time molecular interaction analysis. The company develops biosensors and analytical systems designed to simulate in vivo conditions, enabling the study of interactions between biomolecules such as proteins, antibodies, and cells. Attana’s solutions are utilized in drug development, diagnostics, and life sciences research. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Spotlight Stock Market.